Article may be outdated

This article is 7 days old. Some details may have changed since publication.

The Hindu·2 min read·medium

Aurobindo arm Eugia U.S. recalling antibacterial drug

N
N. Ravi Kumar
Aurobindo arm Eugia U.S. recalling antibacterial drug
✦AI Summary

Eugia U.S. LLC is voluntarily recalling a lot of Vancomycin Hydrochloride injection due to the discovery of glass particles inside the vials. The company is coordinating with distributors to replace the affected medical supplies.

Why it matters

Drug recalls are critical for patient safety and highlight the regulatory oversight required in the pharmaceutical supply chain.

✦Dive DeeperCreate a free account to unlock

HYDERABAD Aurobindo Pharma subsidiary Eugia US LLC is voluntarily recalling a lot of Vancomycin Hydrochloride for Injection USP 1.25g/Vial-30mL (single dose vial) due to presence of particulate matter identified as a glass particle inside the vial. Eugia had shipped the entire lot to wholesalers in the U.S. from September 2-15. It notified the distributors and customers by recall letters and is arranging for return/replacement of all recalled products, the U.S.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthbusiness
✦

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in